ABC
MYGN icon

Associated Banc-Corp’s Myriad Genetics MYGN Stock Holding History

Associated Banc-Corp’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-108
Closed -$2K – 653
2020
Q4 		$2K Hold
108
– – ﹤0.01% 806
2020
Q3 		$1K Buy
+108
New +$1.37K ﹤0.01% 896

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Associated Banc-Corp's MYGN Position: Q1 2021 in Review

Associated Banc-Corp sold out of Myriad Genetics (MYGN) in Q1 2021, closing a stake of 108 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in MYGN in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 197 funds tracked by Wall St. Rank hold MYGN as of Q1 2021.

  • Associated Banc-Corp reported no remaining Myriad Genetics position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 108 Myriad Genetics shares in Q1 2021, an estimated $2K.
  • Associated Banc-Corp first reported a position in Myriad Genetics in Q3 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Myriad Genetics position peaked at $2K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.